• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑素细胞基因特征分类。

The classification of melanocytic gene signatures.

机构信息

Department of Oncological Sciences, University of Utah, Salt Lake City, Utah, USA.

Department of Biomedical Informatics, University of Utah, Salt Lake City, Utah, USA.

出版信息

Pigment Cell Melanoma Res. 2024 Nov;37(6):854-863. doi: 10.1111/pcmr.13189. Epub 2024 Jul 28.

DOI:10.1111/pcmr.13189
PMID:39072997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11518649/
Abstract

Gene expression profiling technologies have revolutionized cell biology, enabling researchers to identify gene signatures linked to various biological attributes of melanomas, such as pigmentation status, differentiation state, proliferative versus invasive capacity, and disease progression. Although the discovery of gene signatures has significantly enhanced our understanding of melanocytic phenotypes, reconciling the numerous signatures reported across independent studies and different profiling platforms remains a challenge. Current methods for classifying melanocytic gene signatures depend on exact gene overlap and comparison with unstandardized baseline transcriptomes. In this study, we aimed to categorize published gene signatures into clusters based on their similar patterns of expression across clinical cutaneous melanoma specimens. We analyzed nearly 800 melanoma samples from six gene expression repositories and developed a classification framework for gene signatures that is resilient against biases in gene identification across profiling platforms and inconsistencies in baseline standards. Using 39 frequently cited published gene signatures, our analysis revealed seven principal classes of gene signatures that correlate with previously identified phenotypes: Differentiated, Mitotic/MYC, AXL, Amelanotic, Neuro, Hypometabolic, and Invasive. Each class is consistent with the phenotypes that the constituent gene signatures represent, and our classification method does not rely on overlapping genes between signatures. To facilitate broader application, we created WIMMS (what is my melanocytic signature, available at https://wimms.tanlab.org/), a user-friendly web application. WIMMS allows users to categorize any gene signature, determining its relationship to predominantly cited signatures and its representation within the seven principal classes.

摘要

基因表达谱技术彻底改变了细胞生物学,使研究人员能够识别与黑色素瘤的各种生物学属性相关的基因特征,例如色素沉着状态、分化状态、增殖与侵袭能力以及疾病进展。尽管基因特征的发现极大地增强了我们对黑素细胞表型的理解,但协调跨独立研究和不同分析平台报告的众多特征仍然是一个挑战。目前用于分类黑素细胞基因特征的方法依赖于精确的基因重叠,并与未标准化的基线转录组进行比较。在这项研究中,我们旨在根据临床皮肤黑色素瘤标本中表达模式的相似性将已发表的基因特征分类为聚类。我们分析了来自六个基因表达库的近 800 个黑色素瘤样本,并开发了一种基因特征分类框架,该框架能够抵抗分析平台中基因识别的偏差以及基线标准的不一致性。使用 39 个经常引用的已发表基因特征,我们的分析揭示了与先前确定的表型相关的七个主要基因特征类:分化型、有丝分裂/MYC 型、AXL 型、无色素型、神经型、低代谢型和侵袭型。每个类别都与组成基因特征所代表的表型一致,并且我们的分类方法不依赖于特征之间的重叠基因。为了促进更广泛的应用,我们创建了 WIMMS(我的黑素细胞特征是什么,可在 https://wimms.tanlab.org/ 上获得),这是一个用户友好的网络应用程序。WIMMS 允许用户对任何基因特征进行分类,确定其与主要引用特征的关系及其在七个主要类别中的代表性。

相似文献

1
The classification of melanocytic gene signatures.黑素细胞基因特征分类。
Pigment Cell Melanoma Res. 2024 Nov;37(6):854-863. doi: 10.1111/pcmr.13189. Epub 2024 Jul 28.
2
Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes.通过基因表达特征对恶性黑色素瘤和良性痣进行诊断区分及其与临床结果的相关性
Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1107-1113. doi: 10.1158/1055-9965.EPI-16-0958. Epub 2017 Apr 4.
3
Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.微管相关蛋白2在良性和恶性黑素细胞中的表达:对皮肤黑素瘤分化和进展的影响
Am J Pathol. 2001 Jun;158(6):2107-15. doi: 10.1016/S0002-9440(10)64682-2.
4
Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue.利用基因表达微阵列特征以及福尔马林固定石蜡包埋组织对黑色素瘤和痣进行分子分类。
Mod Pathol. 2009 Apr;22(4):538-46. doi: 10.1038/modpathol.2009.8. Epub 2009 Mar 6.
5
Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma.转录组分析揭示 I 期黑色素瘤的预后分子特征。
Clin Cancer Res. 2019 Dec 15;25(24):7424-7435. doi: 10.1158/1078-0432.CCR-18-3659. Epub 2019 Sep 12.
6
Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer.利用基因组分析了解黑素细胞肿瘤的进展:从病变区域到癌症
Oncogene. 2003 May 19;22(20):3081-6. doi: 10.1038/sj.onc.1206463.
7
Systematic classification of melanoma cells by phenotype-specific gene expression mapping.基于表型特异基因表达图谱对黑色素瘤细胞进行系统分类。
Pigment Cell Melanoma Res. 2012 May;25(3):343-53. doi: 10.1111/j.1755-148X.2012.00986.x. Epub 2012 Mar 2.
8
Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.基于基因突变分析、拷贝数改变和 DNA 甲基化分析的中枢神经系统黑色素细胞肿瘤的综合基因组分类。
Clin Cancer Res. 2018 Sep 15;24(18):4494-4504. doi: 10.1158/1078-0432.CCR-18-0763. Epub 2018 Jun 11.
9
Value of dopachrome tautomerase detection in the assessment of melanocytic tumors.多巴色素互变异构酶检测在评估黑素细胞肿瘤中的价值。
Melanoma Res. 2014 Jun;24(3):219-36. doi: 10.1097/CMR.0000000000000066.
10
Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy.利用基因表达谱对转移性黑色素瘤进行分子分层:生存结果预测及分子靶向治疗获益情况
Oncotarget. 2015 May 20;6(14):12297-309. doi: 10.18632/oncotarget.3655.

引用本文的文献

1
Single-cell transcriptome analysis suggests cells of the tumor microenvironment as a major discriminator between brain and extracranial melanoma metastases.单细胞转录组分析表明,肿瘤微环境中的细胞是脑转移黑色素瘤和颅外黑色素瘤转移之间的主要鉴别因素。
Biol Direct. 2025 Sep 16;20(1):97. doi: 10.1186/s13062-025-00691-2.
2
Somatic mutations distinguish melanocyte subpopulations in human skin.体细胞突变可区分人类皮肤中的黑素细胞亚群。
bioRxiv. 2025 Feb 8:2025.02.07.637114. doi: 10.1101/2025.02.07.637114.

本文引用的文献

1
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
2
A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma.TCF4 依赖性基因调控网络赋予黑色素瘤对免疫治疗的抗性。
Cell. 2024 Jan 4;187(1):166-183.e25. doi: 10.1016/j.cell.2023.11.037.
3
The journey from melanocytes to melanoma.从黑素细胞到黑色素瘤。
Nat Rev Cancer. 2023 Jun;23(6):372-390. doi: 10.1038/s41568-023-00565-7. Epub 2023 Apr 24.
4
A cellular hierarchy in melanoma uncouples growth and metastasis.黑色素瘤中的细胞层级关系使肿瘤生长和转移解耦。
Nature. 2022 Oct;610(7930):190-198. doi: 10.1038/s41586-022-05242-7. Epub 2022 Sep 21.
5
Museum of spatial transcriptomics.空间转录组学博物馆。
Nat Methods. 2022 May;19(5):534-546. doi: 10.1038/s41592-022-01409-2. Epub 2022 Mar 10.
6
Human melanocyte development and melanoma dedifferentiation at single-cell resolution.单细胞分辨率解析的人类黑素细胞发育与黑色素瘤去分化。
Nat Cell Biol. 2021 Sep;23(9):1035-1047. doi: 10.1038/s41556-021-00740-8. Epub 2021 Sep 2.
7
Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma.强大的基因表达程序是黑色素瘤中反复出现的细胞状态和表型转换的基础。
Nat Cell Biol. 2020 Aug;22(8):986-998. doi: 10.1038/s41556-020-0547-3. Epub 2020 Aug 3.
8
Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities.黑色素瘤的可塑性和表型多样性:治疗障碍与机遇。
Genes Dev. 2019 Oct 1;33(19-20):1295-1318. doi: 10.1101/gad.329771.119.
9
Phenotype plasticity as enabler of melanoma progression and therapy resistance.表型可塑性作为促进黑色素瘤进展和治疗抵抗的因素。
Nat Rev Cancer. 2019 Jul;19(7):377-391. doi: 10.1038/s41568-019-0154-4. Epub 2019 Jun 17.
10
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy.不同免疫细胞群体定义了抗 PD-1 单药治疗和抗 PD-1/抗 CTLA-4 联合治疗的反应。
Cancer Cell. 2019 Feb 11;35(2):238-255.e6. doi: 10.1016/j.ccell.2019.01.003.